Growth Metrics

UNITED THERAPEUTICS (UTHR) Beginning Cash Balance: 2009-2024

Historic Beginning Cash Balance for UNITED THERAPEUTICS (UTHR) over the last 16 years, with Dec 2024 value amounting to $1.2 billion.

  • UNITED THERAPEUTICS's Beginning Cash Balance rose 17.51% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 40.28%. This contributed to the annual value of $1.2 billion for FY2024, which is 25.65% up from last year.
  • As of FY2024, UNITED THERAPEUTICS's Beginning Cash Balance stood at $1.2 billion, which was up 25.65% from $961.2 million recorded in FY2023.
  • UNITED THERAPEUTICS's Beginning Cash Balance's 5-year high stood at $1.2 billion during FY2024, with a 5-year trough of $738.4 million in FY2020.
  • Over the past 3 years, UNITED THERAPEUTICS's median Beginning Cash Balance value was $961.2 million (recorded in 2023), while the average stood at $1.0 billion.
  • In the last 5 years, UNITED THERAPEUTICS's Beginning Cash Balance dropped by 0.04% in 2021 and then increased by 25.65% in 2024.
  • MRY analysis of 5 years shows UNITED THERAPEUTICS's Beginning Cash Balance stood at $738.4 million in 2020, then increased by 0.04% to $738.7 million in 2021, then rose by 21.13% to $894.8 million in 2022, then grew by 7.42% to $961.2 million in 2023, then increased by 25.65% to $1.2 billion in 2024.
  • Its Beginning Cash Balance stands at $1.2 billion for FY2024, versus $961.2 million for FY2023 and $894.8 million for FY2022.